Adaptive Biotech Welcomes Chad Cohen As Its New Chief Financial Officer

SEATTLE--(BUSINESS WIRE)--Adaptive Biotechnologies, the leader in next generation sequencing (NGS) to profile T- and B-cell receptors of the adaptive immune system, announced today the appointment of Chad Cohen as its new Chief Financial Officer, effective immediately. Mr. Cohen has served on Adaptive's Board of Directors since March 2015. Most recently, Mr. Cohen served as CFO for Zillow Group, where he oversaw all finance, treasury and accounting functions and led the finance organization through Zillow's 2011 IPO and nine acquisitions. Dean Schorno, Adaptive's preceding CFO, will step down to pursue a local opportunity in the San Francisco Bay Area where he resides.

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.